The recent research, including a genome-wide meta-analysis (GWMA), bidirectional two-sample Mendelian randomization (TSMR), and pathway enrichment analysis, has established a causal link between increased β2M levels and a higher risk of DLBCL, potentially associated with innate immune system dysfunction [135]. The gene discussed is B2M; the disease is diffuse large B-cell lymphoma.